色谱投稿须知

合集下载

《质谱学报》投稿须知

２Ｏｌ２，３１（４）：４５ — ４９（ｉｎＣｈｉｎｅｓｅ）．
［６］田爱萍．高效液相色谱法测定马来酸二乙酯［Ｊ］．
浙江化１二，２００６，３７（７）：２１ — ２２．
ＴＩＡＮＡｉｐｉｎｇ．ＲＰ— ＨＰＩＣｄｅｔｅｒｍｉｎａｔｉｏｎｏｆｄｉｅｔｈｙｌ
ｙｓｉｓ（ＰａｒｔＢ：ＣｈｅｍｉｃａｌＡｎａｌｙｓｉｓ），２０１１，４７（３）：３４１～３４３（ｉｎＣｈｉｎｅｓｅ）．
［Ｊ］．ＣｈｉｎｅｓｅＪｏｕｒｎａｌｏｆＡｎａｌｙｓｉｓＬａｂｏｒａｔｏｒｙ，
・
述性文摘（含有研究目的、方法、结果和结论）；关键词为３～５个。
・
文稿应采用阿拉伯数字进行分级编号，最多可用４级。引言不编号，也不写“ 引言 ”字样。
・
基金项目名称及项目编号、作者简介（第ｌ作者姓名（出生年一）、性别（民族，汉族省略）、籍贯、职称、学位、从事
ｍａｌｅａｔｅ－ＩＪ］．Ｚｈ＠ａｎｇＣｈｅｍｉｃａｌＩｎｄｕｓｔｒｙ，２００６，３７
（７）：２１ — ２２（ｉｎＣｈｉｎｅｓｅ）．
ｃｈｒｏｍａｔｏｇｒａｐｈｙ－ｍａｓｓｓｐｅｃｔｒｏｍｅｔｒｙ［Ｊ］．Ｊｏｕｒｎａｌｏｆ

《色谱》投稿须知(2007年)

之处。６实验部分
及个人用户提供浏览和订阅。
二栏目设置
研究快报简要报道创新性显著、有首报意义的研究具成果，拟向国外知名刊物投寄稿件的详细摘要。以中文或或英文撰写，文（正文文字、全即图表及参考文献等，中英文摘要另计，同）超过５５０汉字或３０个英文单词。下不０个００研究论文报道创新性、术性较好的完整的研究工作学或阶段性科研成果。以中文撰写，文６０９００。全０～０字０专论与综述以作者自身的研究工作为基础，当前国对
文献即可。
７结果与讨论
用文字或图表描述重要的、代表性的研究发现或实验有数据，对研究结果进行必要的说明、释或推断，解阐明本项研
究在实际工作中的意义或局限性。不能简单地将实验数据或观察事实堆积到文稿中。
维普资讯
《谱》色投稿须知（０７年）２０
一
刊物简介
《色谱》中国化学会主办、国科学院大连化学物理是中
般不超过３字，文文题与中文文题一致，量避免使用缩５英尽略语、号和分子式。各级标题应简短醒目、次分明。符层

分析化学投稿须知

《分析化学》网上投稿须知本编辑部与仪器信息网()合作组建了网上投稿系统,该系统集成了投稿、查询、审稿、修改、清样于一体。

为了不断完善此系统,希望您悉心指教,并告知我们(fxhx@),分析化学编辑部会参照您的建议进行完善,不断加快您稿件的处理周期,以适应当今科技交流日新月异的要求。

您在投稿时,需先登录本刊主页(),点击“我要投稿”,然后按照要求提交论文即可。

以下是本刊对稿件的详细要求,请您仔细阅读。

1、栏目及字数要求1．1 特约来稿邀请分析化学领域知名的国内学者在以下方面进行深入报道:撰写最新的研究成果或者该领域的评述与进展,报道国内学者在国际学术领域活跃的最新研究项目。

该栏目及时追踪分析化学领域最新的发展动向,以图文的特写形式让读者快速掌握近期研究者所关注的态势,广泛传播科学研究对社会的促进作用。

本栏目不收取任何费用,并给予稿酬。

1．2 研究快报论文的创新性强,学术价值重大,投稿时需要对文章的学术价值和创新性进行简要的说明,作者需突出论文的创新思想和初步的研究结果。

撰写格式包括中英文题目、作者、单位、中英文摘要、关键词、正文、参考文献等;同时将篇幅控制在3000 字左右,并提供全文的英文译稿(在ScienceDirect网同步发表)。

发表周期在3 个月内。

1．3 研究报告具有原始性和创造性的研究成果。

全文包括图、表、参考文献和中、英文摘要不得超过6000 字。

1．4 研究简报具有创新性和在前人研究基础上有重大改进的研究成果。

全文包括图、表、参考文献和中、英文摘要不得超过4000 字。

1．5 仪器装置及实验技术主要报道新分析仪器的研制、性能及其应用,实验装置和实验技术的重大改进成果。

全文包括图、表、参考文献和中、英文摘要不得超过5000 字。

1．6 评述与进展评述国内外分析化学前沿的新进展及新动向。

全文连同图、表、参考文献和中、英文摘要不得超过10000 字。

发表的同时必须附英文翻译稿,在ScienceDirect网站同步发表。

《色谱》投稿须知(2019)

(2) 对于经审理认为有发表价值的稿件, 作者须根据审稿意见认真修改, 在指定时间内在线提交修改稿及修改说明, 逐条书面回答审稿意见中提出的问题。并按要求提供参考文献电子版文件、插图文件(要求见本刊网站
/CN/column/column318.shtml 退修说明 ), 及一张反映文章主要创新点和内容的彩图用于制作图文摘要。最终由专家终审后决定是否录用。 (3) 作者需填写《版权转让确认书》, 第一作者和通讯联系人签字并由第一知识产权单位盖章，扫描后在线提交。 (4) 稿件经编辑加工后，将通过E-mail发送文章清样。 (5) 稿件发表后即赠当期《色谱》2 册, 并酌致作者稿酬 (刊出的稿件将提供给相关文摘及全文检索系统, 相关稿酬与本刊稿酬一次性给付)。
电子文献: 主要责任者. 题名. (上传或更新日期) [引用日期]. 获取和访问路径
[4] World Anti-doping Agency. The 2009 Prohibited List International Standard. [2008-08-20]. /rtecontent/document/2009_Prohibited_List_ENG_Final_ 20_Sept_08.pdf
(4) 前言应说明研究背景、意义并突出工作的创新性。实验内容应翔实, 利于他人重复实验。图表应具有自明性, 图表题为中/英文, 图表注为英文。应对所得实验结果与研究目的的关系、是否符合原来的期望、与他人结果的异同进行充分深入的讨论, 并给出合理的推论和结论。结论中应概述研究成果可能的前景及局限性、未能解决的问题以及建议需要进一步研究的课题和方向。
2019 年5月 May 2019
Chinese Journal of Chromatography

《中国中医药信息杂志》投稿指南

2021年1月第28卷第1期中国中医药信息杂志 ·I· 《中国中医药信息杂志》投稿指南《中国中医药信息杂志》1994年创刊，是由国家中医药管理局主管、中国中医科学院中医药信息研究所主办的综合性中医药学术期刊，为中国科技核心期刊和中国科学引文数据库（CSCD）来源期刊。

本刊主要栏目有：标准与规范、资源调查、专题论坛、中医药信息学、实验研究、中药研究与开发、临床研究、经验交流、医院药学、综述。

1 投稿要求和注意事项来稿应具先进性、科学性和逻辑性，数据可靠、论点明确、结构严谨、层次清楚、条理分明、详略得当。

文稿撰写格式和内容应遵循不同类型医学研究的报告规范，如临床随机对照试验（CONSORT声明）、非随机对照试验（TREND）、观察性研究（STROBE）。

投稿前三看：①看投稿须知。

投稿须知是编辑部为使来稿符合期刊的性质、报道方向以及内容编排格式而制定的带有“法规”性质的文件；②看相应栏目范文；③查看自己的文稿。

为了加快稿件处理的速度，本刊实行远程在线投稿（），不再接受其他方式投稿。

为确保编辑部能够将相关信息准确传达到作者，注册投稿者应为第一作者或通讯作者，不宜让他人代投。

论文作者署名应是参与选题和设计，或修改论文中关键性内容者，并按其贡献度大小进行排序。

论文一旦被录用，作者署名及排序则不允许改动，故投稿时请认真核实。

投稿时请同时上传单位介绍信扫描件。

介绍信应注明无一稿两投、不涉及保密及署名无争议等项。

来稿首页请标明以下内容：题名，每位作者的姓名、工作单位（全称），负责与编辑部联系者的联系方式（详细通讯地址、电话号码和电子邮箱）。

忌一稿多投、抄袭剽窃、重复发表、虚假注释等。

为了加强学术道德和学风建设、遏制学术不端行为，本刊编辑部已全面启用中国知网“学术不端文献检索系统”对来稿进行检测，凡涉嫌学术不端行为的将不予采用。

对已通过本刊审稿、等待发表的稿件，作者要求撤稿时，须通过投稿系统提出撤稿要求。

《质谱学报》投稿须知

第４期
苑春莉等：脂肪醇聚氧乙烯醚类非离子表面活性剂的质谱解析及色谱分离研究
２２５
《质谱学报》投稿须知
● 文稿务求论点明确，文字简练，数据可靠。 ● 文题简明（２０个汉字以内）；中英文摘要须包括题目、作者姓名、作者单位、城市名、省名和邮政编码，并写成叙述性文摘（含有研究目的、方法、结果和结论）；关键词为３～５个。 ● 文稿应采用阿拉伯数字进行分级编号，最多可用４级。引言不编号，也不写“ 引言 ”字样。 ● 基金项目名称及项目编号、作者简介（第１作者姓名（出生年～）、性别（民族，汉族省略）、籍贯、职称、学位、从事专业）需在首页以页下注形式写明。 ● 文稿中外文字母、符号须分清大、小写；上下角的字母、数码和符号等位置的高低应区别明显；易混淆的外文字母、符号在第１次出现时用铅笔注明文种。 ● 文稿中的数据不能同时以表和图表述，只能选择其一；采用法定计量单位，物理量用法定量符
术期刊（光盘版）》、《方正Ａｐａｂｉ电子期刊》、《中文科技期刊数据库》、《ＣＥＰＳ中文电子期刊服务》、《书
生数字期刊》和入网“ 万方数据 —— 数字化期刊群” ，本刊所付修稿逾期半年不修回者，本刊即作自动退稿处理；录用稿一经排版，作者要求退稿需部分补偿编

投稿注意事项之表和图

［６］左竞．常见气相色谱仪的清洗及保养（Ｊ］．科技风，２０９，（１９）：
２６９之７１．
指出可能出现故障的各种原因或缩小出现故障原因的范围。最后要注意的是任何样品的改变和差别，溶剂、样品瓶、移液
［７］徐军，刘瑞斌，杨金辉，杨敏霞，李怡文．Ａ￣ｌｅｎｔ６８９０Ｎ型气相色谱仪的日常维护［Ｊ］．实验室科学，２００９，（２）：１５５ — １５８．
２０１３，４１（１５）：１４５ — １４７．
９．２每天：检查进样隔垫，必要时更换；检查气源的气压，剩
３— ５公斤时须及时更换。每周：检查进样口衬管和０型圈，
必要时更换。每月：检查气源接口，进样口、色谱柱连接处检漏。每季度：准备一份色谱柱测试的标样，新购置和使用了一
２０１３。（７）：１８０ — １８１．
９．１严格按照仪器说明书操作，这是做好维护保养的前提条件。按要求做好日常维护，某些部件不得随意拆卸，需请专业工程师来处理。
（１０］权莉，凌世明．浅谈气相色谱仪的维护与保养（Ｊ］．广州化工。
［４］张义．气相色谱法及其在药物分析中的应用［Ｊ］．河北化工，
２０１２，３５（８）：８５．８８．
（５］郑雪红，郑爱榕，曹建平．ＣＰ￣８００气相色谱仪的使用与日常维护

《化工环保》投稿须知

第4期张冰等.液相色谱-质谱法测定水中氨基甲酸酯类农药及其代谢物pray i on i za tion tandem m ass s pectro m e try using a s hortcolu m n .Ana l y Che m Ac t a ,2006,555(2):225~23214陈笑梅,胡贝贞,刘海山等.高效液相色谱-串联质谱法测定粮谷中9种氨基甲酸酯类农药残留.分析化学,2007,35(1):106~11015罗惠明,陈燕勤,梁希扬等.蔬菜、水果中氨基甲酸酯类农药残留量液相色谱-串联质谱检验方法.检验检疫科学,2008,18(5):26~2916宋欢,薛园园,林勤保.超高效液相色谱-电喷雾串联质谱法同时测定坚果中18种氨基甲酸酯类农药残留,分析化学,2009,37(5):782(编辑张艳霞)化工环保投稿须知1总体要求论文主题明确,文字简练,叙述清楚,数据可靠,一般不超过6000字;符合我刊的写作要求与规范。

来稿请采用电子版网上投稿,我刊电子信箱为:hg hb .b j hy @si nopec .co m 。

2文题文题应准确、简明、新颖,能体现主题内容,尽量使用关键词,具有检索价值,一般不超过20个字,不应有非规范的或非公知公认的缩略词、符号、代号、结构式。

3作者及作者简介作者信息:姓名,工作单位,通讯地址,邮编,电话,电子信箱。

作者简介:姓名,出生年,性别,籍贯,学位,职称,研究方向,电话,电邮。

4摘要论文须有中、英文摘要。

摘要应具有独立性和自含性,应尽可能定量化,应是一篇完整的短文。

报道性摘要200~300字,应包含实验目的、方法、结果与结论4要素,重点是结果与结论;英文摘要约170个单词。

指示性摘要约150字,说明论文报道的主要内容。

不要简单重复报告、论文题名中已有的信息。

不使用!本文等作主语,应采用第三人称的写法。

5关键词关键词是反映论文主题内容的单词或词组,一般为3~8个,应尽量选用汉语主题词表提供的叙词,不能用分子式、商品名作主题词。

色谱基础知识简介

1.3.3 检测器
光学检测器热学检测器电化学检测器电学检测器放射性检测器专属型通用型
噪音与漂移，灵敏度，检测限，线性范围, 池体积
• UV检测器
原理：原理：基于被分析组分对特定波长紫外光的选择性吸收定量基础：Lambert-Beer定律，定量基础：Lambert-Beer定律，A＝KCL 定律优点：优点：1）对温度和流速变化不敏感 2）可用于梯度分析缺点：仅适用于测定有紫外吸收的物质缺点： • • • • 与检测器有关的故障排除 1：流动池内有气泡 2：流动池被污染 3：光源灯出现故障
2010-10-22 色谱知识简介
Main content
液相色谱（LC）
原理设备构造
气相色谱（GC）
应用
色谱法 (chromatography)
一种分离技术，由俄国植物学家Mikhail 一种分离技术，由俄国植物学家Mikhail 18世纪初创立世纪初创立。 18世纪初创立。 sweett(茨维特茨维特) S. sweett(茨维特)于
H2 Air
• 过滤系统:
• 除氧. • 活性炭除碳氢化合物。 • 分子筛除水
2
检测器
• 通用型检测器（ Universal Detector) 热导检测器（TCD）氢火焰检测器（FID） • 选择性检测器电子捕获（ECD）脉冲火焰光度检测器（PFPD）氮磷检测器（TSD)
检测器
选择性
塔板理论
例如，图示中塔板数为3.
峰的形状
• 理想的峰型是高斯曲线. • 分子的理论统计学分布
影响色谱柱效率的因素
A. 涡流扩散 (不同路径的影响 ).
• 取决于色谱柱大小、形状和填充的好坏 • 毛细管柱可忽略该项

色谱投稿须知-2010

!"#" 年 # 月 &’()’*+ !"#"
!"#$%&% ’()*$+, (- !"*(.+/(0*+1"2
!"#$ !$ %"$ # #"% & #"’
《色谱》投稿须知（ !"#" 年）
一 $ 刊物简介
( ( 《色谱》是中国化学会主办、中国科学院大连化学物理研究所和国家色谱研究分析中心承办、科学出版社出版、国内外公开发行的专业性学术期刊，于 #)$* 年创刊。主要报道色谱学科的基础性研究成果、色谱及其交叉学科的重要应用成果及其进展，包括新方法、新技术、新仪器在各个领域的应用，以及色谱仪器与部件的研制和开发。适于科研院所等从事色谱基础和应用技术研究的科研人员、色谱及其相关学科的硕士及博士研究生、分析测试领域的基层科研人员、色谱仪器开发及经营单位的有关人员阅读。 ( ( 《色谱》是中文核心期刊、中国科技核心期刊、中国科技精品期刊、中国科协精品科技期刊示范项目中的化学类精品科技期刊。现已被美国《化学文摘》（ ,- ）、《美国医学索引》、俄罗斯《文摘杂志》（ -& ）、日本科学技术文献数（ ./0#1(/ ）据库（ &2,34 ）、波兰《哥白尼索引》（ 2, ）和英国《分析文摘》（ -- ）等 !" 余种国内外重要检索刊物和数据库收录。《色谱》在中国科学技术信息研究所 !"") 年 ## 月公布的《中国科技期刊引证报告（核心版）》中的影响因子为 # $ ")+ ，居分析化学类期刊的第二名。在 ,%52!"") 年底公布的最新影响因子为 # $ ++) ，他引影响因子 # $ "%) ，即年指标为 "$ !)) ， + 年影响因子为 # $ "%# ， * 项指标均为国内化学 6 晶体学学科技术研究类期刊的第一名。 ( ( ! ）研究论文的正文内容：前言，实验部分（包括材料与方法、主要实验步骤，需分节并加小标题），结果与讨论（分节并加小标题），结论。 ( ( + ）专论与综述的正文内容：前言，主体（分节并加小标题），结论与展望。 ( ( * ）技术与应用：前言，实验部分（包括材料与方法、主要实验步骤，需分节并加小标题），结果（分节并加小标题），讨论（可选），结论。 %$ 稿件题名及各级标题 ( ( 题名应准确简洁地反映稿件的主要内容和特色。中英文题名要一致，尽量避免使用缩略语、符号和分子式。各级标题应简短醒目、层次分明。 &$ 作者姓名 ( ( 作者姓名（汉字和汉语拼音）中，通讯联系人的姓名右上方应标注 “ !” 号。作者姓名的汉语拼音，姓要全大写，名字中除首字母大写外其余小写。 ’$ 中英文摘要及关键词 ( ( 摘要是根据稿件正文内容提炼出来的独立的短文。摘要中应高度概括研究或实验目的（通常包括研究背景、研究或实验目的、研究或实验范围）、方法（介绍研究或实验过程、说明所用方法）、结果（列出主要论点和重要数据）和最终结论（研究或实验结果的理论价值或应用价值），四要素缺一不可；摘要中要展示所报道工作的创新和重要之处。特别要强调的是摘要内容均应包含在正文中。中文摘要需 !%" & +"" 字；为了方便国际交流和扩大国际影响，拟投 “研究快报” 及 “ 研究论文” 栏目的稿件，其英文摘要应详细撰写（ !"" & +"" 个单词，提倡用短句表述），不必与中文摘要内容一一对应。 ( ( 每篇稿件应给出 + & $ 个关键词。中英文关键词的顺序要一致。 ($ 首页脚注 ( ( 脚注内容包括： #）通讯联系人的姓名、职称、主要研究方向、电话和电子邮箱； !）若获某项基金资助，需注明该基金项目名称及批准号。 )$ 前言 ( ( 以简洁的语言介绍研究工作的目的和意义（说明为什么要进行这项研究或实验）、研究背景（介绍相关领域内前人及本文作者所做的工作（引用相关文献）、本项工作的创新之处。 *$ 实验部分 ( ( 主要设备应标明型号、名称及制造商。主要试剂或药品应给出来源及纯度等参数。实验材料应给出来源或制备方法。在叙述实验步骤和方法时，不要罗列全部实验过程，只需叙述实验最终确定的主要和关键部分的具体操作步骤。若所采用的方法已公开报道，则引用相关文献即可。 +$ 结果 ( ( 结果是稿件中最重要的部分。数据是表现结果的重要方式，必要时可用照片、图和表格表示；文字用来描述图表中的数据，对研究结果进行必要的说明、解释，与他人结果进行比较，阐明本项工作的意义或局限性，突出本研究的新发现及经过证实的新观点、新见解。

EPA的测定气相色谱法征求意见稿编制说明-中国标准化研究院

《生物产品中DHA、EPA的测定气相色谱法》编制说明（征求意见稿）《生物产品中DHA、EPA的测定气相色谱法》国家标准起草工作小组二〇一九年一月《生物产品中DHA、EPA的测定气相色谱法》编制说明（征求意见稿）一、标准任务的来源、背景及意义本国家标准的制定任务列入国家标准化管理委员会《国家标准委关于下达2018年第二批国家标准制修订计划的通知》（国标委综合〔2018〕41号），项目编号“20180917-T-424”。

该标准由国家重点研发计划项目“生物产业共性技术标准研究”提供支持，由中国标准化研究院提出并归口，由中国水产科学研究院南海水产研究所等单位承担该标准的制定任务。

二十二碳六烯酸（DHA）和二十碳五烯酸（EPA）是人体必需而又不能直接合成的多不饱和脂肪酸（PUFA），在促进婴幼儿视、脑神经发育，改善人脑记忆、治疗心血管疾病、防治老年痴呆以及抗肿瘤、抗氧化等方面有着重要的生理调节功能。

当前国内外市场上富含DHA、EPA的生物产品很多，如深海鱼油、微藻油等，这些产品大多深受消费者欢迎，但是由于产地、加工工艺等原因，其有效成分DHA、EPA含量存在较大差异，因此迫切需要建立起生物产品中DHA、EPA 含量的快速有效的检测方法。

气相色谱（GC）技术是一种高效能，选择性好，灵敏度高，操作简单，应用广泛的分离分析方法，在环境监测、药物分析及工业分析上都得到了广泛的应用。

但是由于它适用于沸点在500℃以下，热稳定性好，相对分子质量在400以下的物质，因此对于生物产品的脂肪酸，用GC直接分析有困难，往往拖尾严重，或被吸附、热解等，为解决这个问题，可采用衍生化技术，即将脂肪酸制成具有一定挥发性的衍生物，使之可以用GC进行测定。

经常使用的是甲酯化试剂，与羧基作用生成相应的甲酯，即可进行GC分析。

采用毛细管柱作为气相色谱柱的毛细管气相色谱法已成为GC分析中的主流，它具有高效、快速、渗透性好、灵敏度高等优点。

但是必须对仪器和操作条件要求严格，特别是对进样和检测器，死体积要小，如连接不当就会影响柱效。

《质谱学报》投稿须知

第２期
吴新华等：高效液相色谱一喷雾串联质谱法快速分析烟草中７种潜香物质超电
９３
《谱学报》稿须知质投
●文稿务求论点明确，文字简练，据可靠。数 ●文题简明（０个汉字以内）中英文摘要须包括题目、者姓名、者单位、市名、２；作作城省名和邮政编码，并写成叙述性文摘（含有研究目的、法、果和结论）关键词为３方结；～５个。 ●文稿应采用阿拉伯数字进行分级编号，多可用４级。引言不编号，最也不写 ” 引言 ” 字样。 ●基金项目名称及项目编号、者简介（１作者姓名（作第出生年～）性别（、民族）籍贯、称、、职学位、从事专业、 — ｉ需在首页以页下注形式写明。Ｅｍａｌ） ●文稿中外文字母、号须分清大、写；下角的字母、符小上数码和符号等位置的高低应区别明显；易混淆的外文字母、号在第１次出现时用铅笔（符电子版用红色）明文种。注 ●文稿中的数据不能同时以表和图表述，只能选择其一；采用法定计量单位，理量用法定量符物号表示，得用废弃的物理量，如压强的单位用帕斯卡（ａ，不例Ｐ）不要用ｂｒａ或者ｔｒ表示；图和表中ｏｒ在用量与单位的比值表示数值，即量与单位之间用除号 “ ” 隔，ｔ／ｎ正文中插图下要写明中英／相如Ｒｍｉ；

《海峡药学》稿件要求

［８］高青，周立春，团静．ＨＰＬＣ — ＥＬＳＤ法测定复方甘露醇注射液中甘
露醇及葡萄糖的含量（Ｊ］．药物分析杂志２００５，２５（５）：５７９．５８１．
《海峡药学》稿件要求
表和图表格采用三线表，两端开口，不用横线、纵线、斜线。上下行数字按个位数对齐，表内数字须
海峡药学
甘露醇标准品和供试品溶液色谱图（见图１、２）。２．５加标回收率实验
２０１３年
第２５卷第１０期
精称取样品１．０００ｇ，每个平行称取３
份，加入甘露醇标准品，按照“ １．２．２ ” 项下处理后进行测定，
冬虫夏草中甘露醇［Ｊ】．理化检验一化学分册，２００３，３９（１０）：５８５ —
５８８．
［６］邓海根，曹雨震．高效液相色谱仪的通用型质量检测器－蒸发光散
射检测器（ＥＬＳＤ）［Ｊ］．药物分析杂志，１９９４，１４（３）：６１４３．［７］汤丹瑜，胡秋芬，杨光宇，等．固相萃取高效液相色谱法测定冬虫一夏草中甘露醇［Ｊ］．理化检验化学分册，２００３，３９（１０）：５８５－５８８．
２．２精密度实验
精密称取胶囊内容物１．０００ｇ，平行操作６
通过实验，在本文所选用的色谱条件下，Ｎ流速为

色谱B投稿需知

JOURNAL OF CHROMATOGRAPHY BAnalytical Technologies in the Biomedical and Life SciencesAUTHOR INFORMATION PACK TABLE OF CONTENTS• Description• Audience• Impact Factor• Abstracting and Indexing • Editorial Board• Guide for Authors p.1p.2p.2p.2p.2p.4ISSN: 1570-0232DESCRIPTIONThe Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches.Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance. Areas to be considered include: •the qualitative and quantitative analysis of biopolymers including proteins, peptides and their post-translational modifications as well as nucleic acids and glycans •the comparative analysis of biological systems using proteomics, genomics, metabonomics and other "omics" approaches•clinical analysis, pharmacokinetics, metabolism, therapeutic drug monitoring, toxicological analysis, doping analysis, veterinary applications, analysis of environmental contaminants in biological systems •the screening and profiling of body fluids, tissues, cells, biological matrices and systems, analysis of endogenous compounds, biomarkers•identification of new bioactive compoundsApplications which utilize published or commercial analytical or preparative protocols with little or no modification or where the results of the application rather than the analytical methodology comprise the major element of novelty of the manuscript should be directed to more specialized journals. Modifications to a previously published method may be considered for a short communication in cases where the improvement in performance is significant. Reports of analytical methods for compounds in early pharmaceutical development often lack general interest and will not be published unless the authors can demonstrate the broader significance of the methodology involved. Quality control analyses of bulk drugs, natural products or pharmaceutical formulations are not within scope.AUDIENCEAnalytical Chemists, Biochemists, Clinical Chemists, Toxicologists. All those concerned with the analysis or preparation of endogenous or exogenous components in biological matrices, or in the interactions of these compounds.IMPACT FACTOR2010: 2.971 © Thomson Reuters Journal Citation Reports 2011ABSTRACTING AND INDEXINGAnalytical AbstractsBIOSISBiochemical AbstractsChemical AbstractsChemical TitlesChromatography AbstractsClinical Chemistry LookoutCurrent Contents / Physics / Chemistry & Earth ScienceCurrent Contents/Life SciencesDeep-Sea Research/Part B: Oceanographic Literature ReviewEMBASEElsevier BIOBASEMEDLINE®Mass Spectrometry BulletinPASCAL/CNRSPharmaceutical AbstractsReferativnyi ZhurnalResearch AlertScience Citation IndexScopusTrends in BiotechnologyEDITORIAL BOARDEditorsR.P.H. Bischoff, Groningen, NetherlandsD.S. Hage, Lincoln, NE, USAG. Hopfgartner, Geneva 4, SwitzerlandH.T. Karnes, Richmond, VA, USAP.J. Taylor, Brisbane, QLD, AustraliaG. Xu, Dalian, ChinaThematic Volume EditorD. Tsikas, Hannover, GermanyEditorial BoardJ. Angerer, Erlangen, GermanyP. Araujo, Bergen, NorwayA.-F. Aubry, New Brunswick, NJ, USAM.G. Bartlett, Athens, GA, USAD. Bhattacharyya, Kolkata, IndiaE.C.Y. Chan, Singapore, SingaporeY. Chen, Beijing, ChinaG.J. de Jong, Utrecht, NetherlandsE. De Lorenzi, Pavia, ItalyY. Deng, Beijing, ChinaA. Guttman, Debrecen, HungaryK. Hamase, Fukuoka, JapanP.C. Ho, Singapore, SingaporeC. Huber, Salzburg, AustriaH. Irth, Amsterdam, NetherlandsJ. Jankowski, Berlin, GermanyU. Karst, Münster, GermanyP. Li, Nanjing, ChinaW. Lindner, Wien, AustriaD.K. Lloyd, New Brunswick, NJ, USAD.M. Lubman, Ann Arbor, MI, USAJ. Macek, Prague, Czech RepublicB.K. Matuszewski, North Wales, PA, USA H.H. Maurer, Homburg/ Saar, Germany D.C. Muddiman, Raleigh, NC, USAM. A. Raggi, Bologna, ItalyJ.M. Rosenfeld, Hamilton, ON, Canada R. Rossi, Siena, ItalyA. Sparreboom, Memphis, TN, USAG. Theodoridis, Thessaloniki, GreeceT-H. Tsai, Taipei, Taiwan, ROCI.W. Wainer, BALTIMORE, MD, USAGUIDE FOR AUTHORSINTRODUCTIONThe Journal of Chromatography B publishes papers on developments in separation science relevant to biology and biomedical research including both fundamental advances and applications. Analytical techniques which may be considered include the various facets of chromatography, electrophoresis and related methods, affinity and immunoaffinity-based methodologies, hyphenated and other multi-dimensional techniques, and microanalytical approaches. The journal also considers articles reporting developments in sample preparation, detection techniques including mass spectrometry, and data handling and analysis.Developments related to preparative separations for the isolation and purification of components of biological systems may be published, including chromatographic and electrophoretic methods, affinity separations, field flow fractionation and other preparative approaches.Applications to the analysis of biological systems and samples will be considered when the analytical science contains a significant element of novelty, e.g. a new approach to the separation of a compound, novel combination of analytical techniques, or significantly improved analytical performance. Areas to be considered include:• the qualitative and quantitative analysis of biopolymers including proteins, peptides and their post-translational modifications as well as nucleic acids and glycans • the comparative analysis of biological systems using proteomics, genomics, metabonomics and other "omics" approaches • clinical analysis, pharmacokinetics, metabolism, therapeutic drug monitoring, toxicological analysis, doping analysis, veterinary applications, analysis of environmental contaminants in biological systems • the screening and profiling of body fluids, tissues, cells, biological matrices and systems, analysis of endogenous compounds, biomarkers • identification of new bioactive compounds Applications which utilize published or commercial analytical or preparative protocols with little or no modification or where the results of the application rather than the analytical methodology comprise the major element of novelty of the manuscript should be directed to more specialized journals. Modifications to a previously published method may be considered for a short communication in cases where the improvement in performance is significant. Reports of analytical methods for compounds in early pharmaceutical development often lack general interest and will not be published unless the authors can demonstrate the broader significance of the methodology involved. Quality control analyses of bulk drugs, natural products or pharmaceutical formulations are not within scope.Types of PaperThe following types of papers are published in the Journal of Chromatography B: Regular research papers (full-length papers), Review articles, Short Communications, Discussions, and Letters to the Editor. Review articles are invited or proposed in writing to the Editors, who welcome suggestions for subjects. An outline of the proposed Review should first be forwarded to the Editors for preliminary discussion prior to preparation. Short Communications are usually descriptions of short investigations, or they can report technical improvements of previously published procedures: they reflect the same quality of research as full-length papers, but should preferably not exceed five printed pages (typically no more than 2850 words (including title, authors and references), with no more than five figures and tables combined).BEFORE YOU BEGINEthics in publishingFor information on Ethics in publishing and Ethical guidelines for journal publication see /publishingethics and /ethicalguidelines.Conflict of interestAll authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also /conflictsofinterest.Submission declaration and verificationSubmission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection software iThenticate. See also /editors/plagdetect.Changes to authorshipThis policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts:Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed.After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article published in an online issue will follow the same policies as noted above and result in a corrigendum.CopyrightUpon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see /copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult /permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult /permissions.Retained author rightsAs an author you (or your employer or institution) retain certain rights; for details you are referred to: /authorsrights.Role of the funding sourceYou are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Please see /funding.Funding body agreements and policiesElsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit /fundingbodies.Open accessThis journal offers you the option of making your article freely available to all via the ScienceDirect platform. To prevent any conflict of interest, you can only make this choice after receiving notification that your article has been accepted for publication. The fee of $3,000 excludes taxes and other potential author fees such as color charges. In some cases, institutions and funding bodies haveentered into agreement with Elsevier to meet these fees on behalf of their authors. Details of these agreements are available at /fundingbodies. Authors of accepted articles, who wish to take advantage of this option, should complete and submit the order form (available at /locate/openaccessform.pdf). Whatever access option you choose, you retain many rights as an author, including the right to post a revised personal version of your article on your own website. More information can be found here: /authorsrights . Language and language servicesPlease write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit /languageediting or our customer support site at for more information.SubmissionSubmission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.Every paper must be accompanied by a letter from the senior author, stating that he/she is submitting the paper for publication in the Journal of Chromatography B.Please submit your article via /locate/jchrombRefereesPlease submit, with the manuscript, the names, addresses and e-mail addresses of 3 potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.PREPARATIONUse of wordprocessing softwareIt is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: /guidepublication). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your wordprocessor.Article structureSubdivision - numbered sectionsDivide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line.IntroductionState the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.Material and methodsProvide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.Theory/calculationA Theory section should extend, not repeat, the background to the article already dealt with in the Introduction and lay the foundation for further work. In contrast, a Calculation section represents a practical development from a theoretical basis.ResultsResults should be clear and concise.DiscussionThis should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.ConclusionsThe main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.AppendicesIf there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc.Essential title page information• Title.Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.• Author names and affiliations.Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes. AbstractA concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. KeywordsImmediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.AbbreviationsDefine abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. AcknowledgementsCollate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).NomenclatureWidely accepted symbols, abbreviations and units (SI) should be used. If there is any doubt about a particular symbol or abbreviation, the full expression followed by the abbreviation should be given the first time it appears in the text. Abbreviations used in tables and figures should be explained in the captions. In general, the recommendations of the International Union of Pure and Applied Chemistry (IUPAC) should be followed and attention should be given to the recommendations of the Analytical Chemistry Division in the journal Pure and Applied Chemistry: Nomenclature for Chromatography, Pure Appl. Chem., 65 (1993) 819-872. Decimal points should be indicated by full stops. All decimal numbers smaller than unity should include a leading zero (e.g. 0.11).Math formulaePresent simple formulae in the line of normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text).FootnotesFootnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.Table footnotesIndicate each footnote in a table with a superscript lowercase letter.ArtworkElectronic artworkGeneral points• Make sure you use uniform lettering and sizing of your original artwork.• Save text in illustrations as 'graphics' or enclose the font.• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.• Number the illustrations according to their sequence in the text.• Use a logical naming convention for your artwork files.• Provide captions to illustrations separately.• Produce images near to the desired size of the printed version.• Submit each figure as a separate file.A detailed guide on electronic artwork is available on our website:/artworkinstructionsYou are urged to visit this site; some excerpts from the detailed information are given here. FormatsRegardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):EPS: Vector drawings. Embed the font or save the text as 'graphics'.TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required. If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'.Please do not:• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;• Supply files that are too low in resolution;• Submit graphics that are disproportionately large for the content.Color artworkPlease make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regardingthe costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or on the Web only. For further information on the preparation of electronic artwork, please see /artworkinstructions.Please note: Because of technical complications which can arise by converting color figures to 'gray scale' (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.Figure captionsEnsure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used. TablesNumber tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.ReferencesCitation in textPlease ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication' Citation of a reference as 'in press' implies that the item has been accepted for publication.Web referencesAs a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.References in a special issuePlease ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.Reference management softwareThis journal has standard templates available in key reference management packages EndNote (/support/enstyles.asp) and Reference Manager (/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only need to select the appropriate journal template when preparing their article and the list of references and citations to these will be formatted according to the journal style which is described below. Reference StyleReference StyleText: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.Example: "..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ...."List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.Examples:Reference to a journal publication:[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, J. Sci. Commun. 163 (2000) 51.Reference to a book:[2] W. Strunk Jr., E.B. White, The Elements of Style, Macmillan, New York, 3rd ed., 1979. Reference to a chapter in an edited book:[3] G.R. Mettam, L.B. Adams, in: B.S. Jones, R.Z. Smith (Eds.),Introduction to the Electronic Age, E-Publishing, New York, 1994, p. 281.Journal abbreviations sourceJournal names should be abbreviated according to。

作者修改稿件要求-色谱

作者修改稿件要求A：正文请逐项阅读并对照检查文章内容，如有不符之处请加以修改或补充。

1.为了便于了解稿件的修改情况,请您:(1)在修改稿寄回时以书面形式逐条回答审稿人提出的每一个问题,说明是否接受审稿人的意见，是否在文章中作了修改以及是如何修改的,如不同意审稿人的意见或未作修改的,请提出您的理由。

为了不使读者产生同样的问题,所作的说明或解释应尽可能反映在修改稿中,(2)在修改稿中标出与原稿不同之处(可在修改过的文字下面画线)2.文章题目应明确简洁地反映研究成果的实质和特点，长短适宜，不使用不规范的缩略语、3.国外作者的姓名请写全称,名字部分不要缩写。

国外单位请用中文写出单位名称、城市、4.作者的工作单位应写标准的对外全称(包括英文名称)5.(1)第一作者简介,(2)(3)基金资助项目的基金名称和项目批准号。

(4)刊出文稿将由本刊编辑部提供给有关文摘检索刊物及光盘出版物编辑部，如作者不同意提供，请注明,否则视为同意。

6.各类稿件均需200～3007.各类稿件均需有3～8个关键词(中、英文关键词(包括顺序)要一致)，化合物和表征手段等名词应采用中文名称,8.在前言中应阐明研究工作的背景、意义及本文的创新之处,对国内外有关的研究状况进行较为全面的介绍,9.10.“实验部分”应详细叙述实验方法和实验条件,试剂和仪器应用中文标明规格、生产厂家、型号及名称,11.物理量、计量单位及其符号应按照国家标准执行。

请特别注意浓度单位的表示方法：不能用ppm, ppb等表示某物质的含量(不符合国家标准)，应根据不同情况分别改为质量分数、体积分数、摩尔分数或质量浓度(g/L)等；浓度为百分数时应指明是质量分数还是体积分数；两种物质之比应注明是质量比、摩尔比还是体积比。

本刊常用的单位：秒s(不用sec),分钟min,小时h(不用hr,hrs),天d(不用day),浓度mol/L(不用M或N), 压力Pa(用psi,atm,Torr,bar者都应换算为Pa或kPa,MPa),长度nm(不用A),转速r/min(不用rpm和kgf表示离心效率),化学位移的单位是1(可不写,用ppm者应去掉ppm)。

各国药典色谱法-概述说明以及解释

各国药典色谱法-概述说明以及解释1.引言1.1 概述概述色谱法是一种有效的分离和分析化学物质的方法。

在药学领域，药典中对药物的色谱法进行了详细的规定和说明。

不同国家的药典中对色谱法的要求和标准有所不同，这是由于各个国家在药物研发和生产方面的不同需求和特点所决定的。

本文将综合介绍各国药典中关于色谱法的规定和标准。

首先，我们将对各国药典进行整体概述，包括其出版机构、发布周期和权威性等方面的内容。

然后，我们将详细分析各国药典中对色谱法的要求，涵盖色谱技术、仪器设备要求、样品准备和柱填充剂等方面的内容。

另外，我们还将比较各国药典中对于色谱法方法验证、方法开发和方法转移的规定，探讨其异同点和实际应用。

本文的目的是为读者提供一个全面了解各国药典中色谱法的情况的视角，帮助读者更好地理解和运用色谱法进行药物分析。

同时，通过对各国药典的比较研究，我们也可以发现不同国家在药物分析方面的研究重点和发展趋势，为我国药物分析领域的发展提供借鉴和参考。

在接下来的章节中，我们将详细讨论各国药典中关于色谱法的规定和标准，并对其进行分析和总结。

通过对各国药典的比较研究，我们将为读者呈现一个全面、系统的各国药典色谱法的景象，希望能够为广大药学工作者提供有益的参考和指导。

1.2 文章结构文章结构部分的内容可以参考以下例子进行撰写：文章结构：本文主要分为引言、正文和结论三个部分。

引言部分概述了本文的主要内容和目的，介绍了各国药典色谱法的研究背景和重要性。

正文部分主要分为两个部分，第一部分介绍了各国药典的概念和作用，第二部分重点介绍了色谱法在药典中的应用和发展。

结论部分总结了各国药典色谱法的研究现状，展望了未来的发展方向。

引言部分的概述：引言部分将介绍各国药典色谱法的研究背景和重要性。

首先，药典是各个国家用来规范药品质量标准的重要参考资料，对保障人们的用药安全具有重要意义。

其次，色谱法作为一种常用的分析方法，在药典中被广泛应用。

其准确性、灵敏度和可靠性被广泛认可。

《分析化学》网上投稿须知

《分析化学》网上投稿须知《分析化学》编辑部与仪器信息网（）合作组建的网上投稿系统现已初步建成。

形成了以投稿、查询、审稿、修改、清样于一体的业务流程。

欢迎您使用此投稿系统，其中有什么不完善的地方，希望您悉心指教，并告知我们（fxhx@），分析化学编辑部会按照您的建议进行完善，力图使整个系统帮助您加快稿件的处理周期，达到适应当今科技交流日新月异的要求。

首先您需要登录分析化学编辑部的网址：在主页上可以看到“我要投稿”字样，按照要求提交论文即可。

以下是本刊对稿件的详细要求，请您仔细阅读。

1栏目及字数要求本刊设特约来稿、研究报告、研究简报、仪器装置及实验技术、评述与进展、NEWS 等栏目。

1.1 特约来稿邀请分析化学领域知名的国内学者在以下方面进行深入报道: 撰写最新的研究成果或者该领域的评述与进展，报道最新的国内学者在国际学术领域活跃的研究项目。

该栏目及时追踪分析化学领域最新的发展动向，以图文的特写形式让读者快速掌握近期研究者所关注的态势，广泛传播科学研究对社会的促进作用。

本栏目不收取任何费用，并给予稿酬。

1.2研究报告具有原始性和创造性的研究成果。

全文连同图、表、参考文献和中、英文摘要不得超过6000字。

1.3 研究简报具有创新性和在前人研究基础上有重大改进的研究成果。

全文连同图、表、参考文献和中、英文摘要不得超过4000字。

1.4 仪器装置及实验技术主要报道新分析仪器的研制、性能及其应用，实验装置和实验技术的重大改进成果。

全文连同图、表、参考文献和中、英文摘要不得超过5000字。

1.5 评述与进展评述国内外分析化学前沿的新进展及新动向。

全文连同图、表、参考文献和中、英文摘要不得超过10000字。

发表的同时必须附英文翻译稿，同步刊登在Elsevier 网站上。

1.6 NEWS 介绍国内学者在国际知名期刊发表的论文。

主要以中文的形式提供论文的概述性的摘要，内容包括研究的目的、操作条件、必要的数据和结论，以及对未来应用潜力的预测，同时配以主题图片；篇幅不超过1000字。

投稿须知-分析化学

２、来稿要求和注意事项2．1涉及与本职工作有关的成果，投稿时请附单位介绍信及作者简况(年龄、性别、技术职称及研究方向等)，由单位负责稿件密级、质量和署名顺序等的审查。

获奖或有重大效益论文请附说明和有关证件复印件。

发表之后获奖论文望来函告知，本刊将酌赠刊物。

来稿注明通讯联系人或第一作者的电话和电子信箱。

2．2来稿应观点明确，数据准确、完整，文字精练，层次分明。

中、英文摘要必须包含本文主要目的、方法(条件)和贡献的具体简要内容，力戒空洞。

英文摘要(正文)以不少于1000字符为宜，应包含实验方法，重要的实验数据和结论等信息。

引言部分应扼要说明研究工作的目的、意义，前人有关工作状况及本文的创新点。

稿件用A4幅面纸排版，稿件图、表须工整清楚，不得自造简化字。

英文摘要应独占一面并另附一相应的中文译件。

不符合上述要求的稿件，编辑部将不予受理。

2．3论文中的中、英文摘要明确写明重要的实验条件、数据和结论。

文中插图清晰，坐标标度准确标明。

图、表均需附题并编号，文中图题、图注；表题、表头、表中内容及表注均全部采用中、英文对照表述(中文列前)。

图、表题号及图中曲线号一律用阿拉伯数字标注。

图题及图注应在图下方注明。

表格请采用三线制列出。

文中图、表应尽量精简或改用文字说明。

图与表内容不得重复。

文中结构式应仔细绘制清楚。

2．4研究报告、研究简报、仪器装置与实验技术、评述与进展四栏稿件，需在文中相应位置加中、英文摘要及中、英文一致的关键词。

关键词请参照《汉语主题词》选择。

2．5稿件中计量单位及符号必须按“中华人民共和国国家计量标准”及有关GB 标准规定书写。

物理量的符号一律用斜体字母，单位符号和词头用正体字母。

2．6文中公式、外文字母、拉丁字母和希腊字母，大写、小写、正体、斜体、黑体或符号、上角、下角等，应用铅笔加旁注。

结构式一般不得夹杂于行文中，而应以适当的化学名称或分子式表示。

2．7化学名词术语，请参照中国化学会推荐的“化学命名原则”书写。

色谱方法验证审评指南

色谱方法验证审评指南绪言本技术指南的目的是给审评人员审评验证色谱方法的，该文件讨论色谱方法的要点和不足，以便CDER的审评人员能够保证方法的良好性能，也使化学工作者了解为通过审评应给出的足够的信息。

国际协调会议（ICH）1993年定义的分析术语，已在这一指南中运用。

色谱方法通常用于原料、药物、药物制剂和生物体液中化合物的定性和定量。

涉及的成分包括手性的或非手性的药物、过程杂质、残留溶媒、附加剂如防腐剂、分解产物、从容器和密闭包装或制造过程中带入的可提取和可过滤的杂质、植物药中的农药和代谢物等。

试验方法的目的是得到可信赖的和准确的数据，无论是用于验收、出厂、稳定性或药物动力学研究。

得到的数据用于药品开发或批准后的定性和定量，试验包括原料的验收、药物和药物制剂的出厂、过程检验(In- process testing)的质量保证和失效期的建立。

方法的验证是由药品的开发者或使用者来检验其方法是否达到预期的可靠性、准确度和精密度的过程。

得到的数据成为方法的验证资料的一部分交给CDER.。

方法的验证对于完成机构满足档案要求不是一次性的，开发者和使用者都应验证其方法的耐用度或耐久性（ruggedness or robustness.），其他的分析者、用其它相当的仪器，在其它的日期或地点，在药品生产期限(有效期)全过程，方法都应能够重现。

如果产生数据的方法是可靠的，那么所得到的验收、出厂、稳定性或药物动力学的数据就是可信赖的。

验证的过程和方法的设计应在开发过程中重要的数据产生之前，如果方法改变了，还应该再验证。

---------------------------------------------------------------------------------------------------------------------- 这一指南由FDA-CDER化学制造控制协调委员会(CMCCC)的分析方法技术委员会制作。

色谱投稿须知

《质谱学报》投稿须知

《色谱》投稿须知(2007年)

分析化学 投稿须知

《色谱》投稿须知(2019)

《中国中医药信息杂志》投稿指南

《质谱学报》投稿须知

投稿注意事项之表和图

《化工环保》投稿须知

色谱基础知识简介

色谱投稿须知-2010

EPA的测定气相色谱法征求意见稿编制说明-中国标准化研究院

《质谱学报》投稿须知

《海峡药学》稿件要求

色谱B投稿需知

作者修改稿件要求-色谱

各国药典色谱法-概述说明以及解释

《分析化学》网上投稿须知

投稿须知-分析化学

色谱方法验证审评指南

分析化学投稿须知